Literature DB >> 24389445

An uncommon insertion mutation in exon 19 of EGFR showed stable disease after TKI treatment.

Anthony W H Chan1, Joanna H M Tong, Sing-Hung Lo, Ka Fai To.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24389445     DOI： 10.1097/JTO.0b013e3182a471e0

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib.

Authors:  Abed Agbarya; Meira Melamed-Frank; Orit Kaidar-Person; Ilana Goldberg-Cohen; Haitam Nasrallah; Mira Wollner; Jair Bar; Gad Rennert; Flavio Lejbkowicz
Journal:  Springerplus       Date:  2014-09-09

Review 2.  Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy.

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Cancer Sci       Date:  2016-08-09       Impact factor: 6.716

3.  Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients.

Authors:  Jian Su; Wenzhao Zhong; Xuchao Zhang; Ying Huang; Honghong Yan; Jinji Yang; Zhongyi Dong; Zhi Xie; Qing Zhou; Xiaosui Huang; Danxia Lu; Wenqing Yan; Yi-Long Wu
Journal:  Oncotarget       Date:  2017-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.